Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05690971

Psychosocial Mobile App for Chronic Graft-Versus-Host Disease

Conditions: Chronic Graft-Versus-Host Disease, Allogeneic Stem Cell Transplant

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 120
Sponsor: Massachusetts General Hospital

Location: United States

Summary

The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)

Eligibility Criteria

Inclusion Criteria:Adult patients (≥18 years) who underwent allogeneic hematopoietic stem cell transplant (HCT).Have moderate to severe chronic GVHD based on their oncology clinician assessment as documented in the Electronic Health Record.Ability to comprehend and speak English as the HORIZONs app is only available in English.Exclusion Criteria:-Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05690971). StuddyBuddy aggregates publicly available trial information.